Administration Links Prenatal Tylenol to Autism

President Trump and HHS leaders warned that prenatal use of acetaminophen (Tylenol) “can be associated” with a higher risk of autism and urged pregnant women to avoid it unless medically necessary. Global and U.S. medical authorities — including the WHO, European Medicines Agency, CDC, the American College of Obstetricians and Gynecologists and major autism research groups — said the evidence is inconsistent, largely observational, and does not establish causation. The announcement prompted immediate public pushback, social‑media protests of people defiantly taking Tylenol, and satire over gaffes during the presentation. Some clinicians cautioned that untreated fever in pregnancy can pose risks and urged measured, medically supervised use, while local hospitals said they will wait for peer‑reviewed evidence before changing practice. The FDA is reportedly considering updating label language to note possible associations without declaring a causal link.